TrialBritish journal of cancer2002

Sequential or alternating administration of docetaxel (Taxotere) combined with FEC in metastatic breast cancer: a randomised phase II trial.

M Spielmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.